# Measurement of Percentage Depth–Dose Distributions in Clinical Dosimetry: Conventional Techniques and Emerging Sensor Technologies

## TL;DR

This paper reviews traditional and new sensor technologies for measuring radiation dose depth in radiotherapy, aiming to improve accuracy and efficiency.

## Contribution

The paper systematically evaluates emerging sensor technologies for PDD measurement, highlighting their potential to enhance clinical dosimetry.

## Key findings

- Conventional techniques like ionization chambers and radiochromic film have established accuracy but face limitations in resolution and speed.
- Emerging sensors such as multi-layer chambers and scintillator-based detectors offer real-time and high-resolution PDD measurements.
- No single technology currently meets all clinical requirements, but integrating new sensors promises improved radiotherapy quality assurance.

## Abstract

Percentage depth–dose (PDD) distributions are fundamental to characterizing radiation beams in radiotherapy. This review provides an overview of both methods and sensor technologies for measuring PDD in photon, electron, proton, and carbon-ion beams. We summarize conventional dosimetry techniques, including water-phantom scanning with ionization chambers (cylindrical and parallel-plate) and radiochromic film, and discuss their strengths (established accuracy, calibration traceability) and limitations (volume averaging, delayed readout). We then examine emerging sensor technologies designed to improve spatial resolution, speed, and radiation hardness: multi-layer ionization chambers and Faraday cups for one-shot PDD acquisition; scintillator-based detectors (liquid, plastic, and fiber-optic) enabling real-time and high-resolution depth–dose measurements; advanced semiconductor detectors including silicon carbide diodes; as well as novel approaches such as ionoacoustic range sensing for proton beams. For each modality and detector type, we emphasize clinical relevance, measurement accuracy, spatial resolution, radiation durability, and suitability for high dose-per-pulse environments (e.g., FLASH radiotherapy). Current challenges, such as detector response in regions of steep dose gradient, saturation or recombination at ultra-high dose rates, and energy-dependent sensitivity in mixed radiation fields, are analyzed in detail. We also highlight the limitations of each technique and discuss ongoing improvements and prospects for clinical implementation. In summary, no single detector technology fully satisfies all requirements for fast, high-accuracy, high-resolution, radiation-hard PDD measurement, but the integration of emerging sensor innovations into clinical dosimetry promises to enhance the precision and efficiency of radiotherapy quality assurance.